Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' POLYZOS A' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 24 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Polyzos, A; Tsavaris, N; Kosmas, C; Arnaouti, T; Kalahanis, N; Tsigris, C; Giannopoulos, A; Karatzas, G; Giannikos, L; Sfikakis, PP
      Hypersensitivity reactions to carboplatin administration are common but not always severe: A 10-year experience

      ONCOLOGY
    2. Kosmas, C; Tsavaris, N; Vadiaka, M; Stavroyianni, N; Koutras, A; Malamos, N; Onyenadum, A; Rokana, S; Polyzos, A; Kalofonos, HP
      Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens

      CANCER
    3. Polyzos, A; Kosmas, C; Tsavaris, N; Markopoulos, C; Kalahanis, N; Papadopoulos, O; Arnaouti, T; Sfikakis, PP
      Doxorubicin plus ifosfamide as salvage treatment for patients with advanced breast cancer refractory to epirubicin plus cyclophosphamide

      CLINICAL DRUG INVESTIGATION
    4. Kosmas, C; Tsavaris, NB; Polyzos, A; Kalofonos, HP; Sepsas, E; Malamos, NA; Vadiaka, M; Dosios, T; Antonopoulos, MJ
      A Phase II study of paclitaxel-ifosfamide-cisplatin combination in advanced nonsmall cell lung carcinoma

      CANCER
    5. Kosmas, C; Tsavaris, NB; Polyzos, A; Malamos, NA; Katsikas, M; Antonopoulos, MJ
      Phase I study of dose-escalated paclitaxel, ifosfamide, and cisplatin (PIC) combination chemotherapy in advanced solid tumours

      BRITISH JOURNAL OF CANCER
    6. Polyzos, A; Bramis, J; Delladetsima, JK; Sfikakis, PP
      Prolonged survival in metastatic adenocarcinoma of the small intestine treated with irinotecan

      CLINICAL DRUG INVESTIGATION
    7. Polyzos, A; Daskalopoulou, E; Giannitsiotis, E; Gatzonis, S; Sfikakis, PP
      Transient encephalopathy followed by seizures after docetaxel infusion

      CLINICAL DRUG INVESTIGATION
    8. Polyzos, A; Tsavaris, N; Kosmas, C; Petrikos, G; Stamatiadis, D; Kalahanis, N; Giannopoulos, A; Karatzas, G; Sfikakis, PP
      Double biochemical modulation of 5-fluorouracil by methotrexate and folinic acid for the treatment of advanced colorectal cancer

      CLINICAL DRUG INVESTIGATION
    9. Polyzos, A; Tsavaris, N; Kosmas, C; Petrikos, G; Giannikos, L; Kalahanis, N; Papadopoulos, O; Christodoulou, K; Giannakopoulos, K; Veslemes, M; Katsilambros, N
      Second-line chemotherapy with cisplatin-ifosfamide in patients with ovarian cancer previously treated with carboplatin-cyclophosphamide

      JOURNAL OF CHEMOTHERAPY
    10. Polyzos, A; Tsavaris, N; Kosmas, C; Giannikos, L; Katsikas, M; Kalahanis, N; Karatzas, G; Christodoulou, K; Giannakopoulos, K; Stamatiadis, D; Katsilambros, N
      A comparative study of intraperitoneal carboplatin versus intravenous carboplatin with intravenous cyclophosphamide in both arms as initial chemotherapy for stage III ovarian cancer

      ONCOLOGY
    11. VESLEMES M; POLYZOS A; LATSI P; DIMITROULIS J; STAMATIADIS D; DARDOUFAS C; RASIDAKIS A; KATSILAMBROS N; JORDANOGLOU J
      OPTIMAL DURATION OF CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER - A RANDOMIZED STUDY OF 4 VERSUS 6 CYCLES OF CISPLATIN-ETOPOSIDE

      Journal of chemotherapy
    12. PAPAKOSTAS P; RIGATOS S; STATHOPOULOS GP; SAMELIS G; POLYZOS A; FOUNTZILAS G
      2ND LINE CHEMOTHERAPY WITH PACLITAXEL AND CARBOPLATIN IN ADVANCED GASTRIC-CANCER

      Annals of oncology
    13. POLYZOS A; TSAVARIS N; KOSMAS C; ARNAOUTIS T; APOSTOLOPOULOS P; VAFIADIS I; TSATALI K; TOSKAS A; NIKOU G
      GEMCITABINE(GEM) PLUS B-FLUOROURACIL (5-FU) BY MODULATED BY LEUCOVORIN (LV) FOR ADVANCED PANCREATIC-CANCER)

      Annals of oncology
    14. KOSMAS C; TSAVARIS N; POLYZOS A; SEPSAS E; MALAMOS N; KALOFONOS HP; PANOPOULOS C; ANTONOPOULOS MJ
      PACLITAXEL (TAXOL)-IFOSFAMIDE-CISPLATIN (TIP) CHEMOTHERAPY (CMT) REGIMEN IN PATIENTS (PTS) WITH ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC) - A PHASE-II STUDY

      Annals of oncology
    15. RASSIDAKIS GZ; DELLADETSIMA JK; LETSOS SP; POLYZOS A; YANNOPOULOS A
      HEPATOID ADENOCARCINOMA OF THE STOMACH WITH EXTENSIVE NEUROENDOCRINE DIFFERENTIATION AND A COEXISTING CARCINOID-TUMOR

      Histopathology
    16. POLYZOS A; TSAVARIS N; VESLEMES M; DARDOUFAS K; DOSIOS T; KOSMAS C
      CHEMOTHERAPY OF NON-SMALL-CELL LUNG-CANCER - A PROSPECTIVELY RANDOMIZED STUDY OF CISPLATIN-ETOPOSIDE VERSUS CISPLATIN-MITOMYCIN-VINBLASTINE

      Journal of chemotherapy
    17. POLYZOS A; TSAVARIS N; GIANNIKOS L; KALAHANIS N; CHRISTODOULOU K; GIANNAKOPOULOS K; NIKOU G; TOSKAS A; PAPARGYRIOU J; KATSILAMBROS N
      PACLITAXEL (PX) CARBOPLATIN (CBP) VERSUS CYCLOPHOSPHAMIDE (CTX)-CARBOPLATIN SUPPORTED BY G-CSF AS FIRST LINE CHEMOTHERAPY IN FIGO III-IV OVARIAN-CARCINOMA (OC)

      European journal of cancer
    18. KOSMAS C; TSAVARIS N; POLYZOS A
      PHASE I II STUDY OF TAXOL/IFOSFAMIDE/CISPLATIN (TIP) COMBINATION CHEMOTHERAPY (CMT) IN ADVANCED SOLID TUMORS (ST)/

      European journal of cancer
    19. TSAVARIS N; POLYZOS A; KOSMAS C; GIANNIKOS L; GOGAS J
      A FEASIBILITY STUDY OF 1-H PACLITAXEL INFUSION IN PATIENTS WITH SOLIDTUMORS

      Cancer chemotherapy and pharmacology
    20. POLYZOS A; NIKOU G; GIANNOPOULOS A; TOSKAS A; KALAHANIS N; PAPARGYRIOU J; MICHAIL P; PAPACHRISTODOULOU A
      CHEMOTHERAPY OF BILIARY-TRACT CANCER WITH MITOMYCIN-C AND 5-FLUOROURACIL BIOLOGICALLY MODULATED BY FOLINIC ACID - A PHASE-II STUDY

      Annals of oncology
    21. POLYZOS A; TSAVARIS N; GIANNOPOULOS A; BACOYIANNIS C; PAPADIMAS V; KALAHANIS N; KARATZAS G; KOSMAS C; SAKELAROPOULOS N; ARCHIMANDRITIS A; PAPACHRISTODOULOU A; KOSMIDIS P
      BIOCHEMICAL MODULATION OF FLUOROURACIL - COMPARISON OF METHOTREXATE, FOLINIC ACID, AND FLUOROURACIL VERSUS FOLINIC ACID AND FLUOROURACIL INADVANCED COLORECTAL-CANCER - A RANDOMIZED TRIAL

      Cancer chemotherapy and pharmacology
    22. VESLEMES M; POLYZOS A; LATSI P; DIMITROULIS J; DIMAKOU K; JORDANOGLOU J
      OUTCOME OF PATIENTS WITH BRAIN METASTASES AFTER COMBINED-MODALITY THERAPY IN SMALL-CELL LUNG-CANCER (SCLC) - A RETROSPECTIVE STUDY

      Journal of chemotherapy
    23. VESLEMES M; POLYZOS A; LATSI P; DIMITROULIS J; ORPHANIDOU D; RASIDAKIS A; JORDANOGLOU J
      4 VERSUS 6 COURSES CISPLATIN ETOPOSIDE (EP) WITH EARLY CHEST RADIOTHERAPY - A RANDOMIZED STUDY IN SMALL-CELL LUNG-CANCER (SCLC)

      European journal of cancer
    24. POLYZOS A; GIANNIKOS L; VESLEMES M; KALAHANIS N; GIANOPOULOS A; GIANNAKOPOULOS K; CHRISTODOULOU K
      CISPLATIN (C) PLUS IFOSFAMIDE (I) FOR PATIENTS WITH OVARIAN-CARCINOMA(OC) WITH PRIOR CARBOPLATIN (CBT) PLUS CYCLOPHOSPHAMIDE (CTX) CHEMOTHERAPY

      European journal of cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/10/20 alle ore 19:27:27